Role of stem cells in cancer therapy and cancer stem cells: A review

Cancer Cell International

Volumn 7, Issue , 2007, Pages

  Sagar, Jayesh ^a,b   Chaib, Boussad ^b   Sales, Kevin ^b   Winslet, Marc ^a,b   Seifalian, Alexander ^a,b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; AMIFOSTINE; ANTINEOPLASTIC AGENT; CYCLOPAMINE; DOCETAXEL; GRANULOCYTE COLONY STIMULATING FACTOR; IMATINIB; LITHIUM SALT; MONOCLONAL ANTIBODY; PACLITAXEL; RECOMBINANT ERYTHROPOIETIN; RITUXIMAB; STEM CELL FACTOR;

B CELL LYMPHOMA; BONE MARROW; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STEM CELL; CANCER SURVIVAL; CARCINOGENESIS; CELL ISOLATION; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG MEGADOSE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; LIFESPAN; MALIGNANT NEOPLASTIC DISEASE; MEDULLOBLASTOMA; MULTIPLE MYELOMA; NONHUMAN; PERIPHERAL BLOOD STEM CELL; REVIEW; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TUMOR IMMUNITY;

EID: 34347363095     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-7-9     Document Type: Review

References (127)

1. Reya T Morrison SJ Clarke MF Weissman IL Stem cells, cancer, and cancer stem cells Nature 2001 414 105-111 10.1038/35102167 11689955
2. Soltysova A Altanerova V Altaner C Cancer stem cells Neoplasma 2005 52 435-440 16284686
3. Jiang Y Jahagirdar BN Reinhardt RL Schwartz RE Keene CD Ortiz-Gonzalez XR Reyes M Lenvik T Lund T Blackstad M Du J Aldrich S Lisberg A Low WC Largaespada DA Verfaillie CM Pluripotency of mesenchymal stem cells derived from adult marrow Nature 2002 418 41-49 10.1038/nature00870 12077603
4. Kim CF Jackson EL Woolfenden AE Lawrence S Babar I Vogel S Crowley D Bronson RT Jacks T Identification of bronchioalveolar stem cells in normal lung and lung cancer Cell 2005 121 823-835 10.1016/ j.cell.2005.03.032 15960971
5. Hatfield SD Shcherbata HR Fischer KA Nakahara K Carthew RW Ruohola-Baker H Stem cell division is regulated by the microRNA pathway Nature 2005 435 974-978 10.1038/nature03816 15944714
6. Thomson JA Itskovitz-Eldor J Shapiro SS Waknitz MA Swiergiel JJ Marshall VS Jones JM Embryonic stem cell lines derived from human blastocysts Science 1998 282 1145-1147 10.1126/science.282.5391.1145 9804556
7. Serakinci N Guldberg P Burns JS Abdallah B Schrodder H Jensen T Kassem M Adult human mesenchymal stem cell as a target for neoplastic transformation Oncogene 2004 23 5095-5098 10.1038/sj.onc.1207651 15107831
8. Sylvester KG Longaker MT Stem cells: Review and update Arch Surg 2004 139 93-99 10.1001/archsurg.139.1.93 14718284
9. Simonsen JL Rosada C Serakinci N Justesen J Stenderup K Rattan SI Jensen TG Kassem M Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells Nat Biotechnol 2002 20 592-596 10.1038/nbt0602-592 12042863
10. Awad HA Wickham MQ Leddy HA Gimble JM Guilak F Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds Biomaterials 2004 25 3211-3222 10.1016/ j.biomaterials.2003.10.045 14980416
11. Lee OK Kuo TK Chen WM Lee KD Hsieh SL Chen TH Isolation of multipotent mesenchymal stem cells from umbilical cord blood Blood 2004 103 1669-1675 10.1182/blood-2003-05-1670 14576065
12. Miura M Gronthos S Zhao M Lu B Fisher LW Robey PG Shi S SHED: Stem cells from human exfoliated deciduous teeth Proc Natl Acad Sci U S A 2003 100 5807-5812 156282 12716973 10.1073/pnas.0937635100
13. Sottile V Halleux C Bassilana F Keller H Seuwen K Stem cell characteristics of human trabecular bone-derived cells Bone 2002 30 699-704 10.1016/S8756-3282(02)00674-9 11996907
14. Pittenger MF Mackay AM Beck SC Jaiswal RK Douglas R Mosca JD Moorman MA Simonetti DW Craig S Marshak DR Multilineage potential of adult human mesenchymal stem cells Science 1999 284 143-147 10.1126/ science.284.5411.143 10102814
15. Dragoo JL Samimi B Zhu M Hame SL Thomas BJ Lieberman JR Hedrick MH Benhaim P Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads J Bone Joint Surg Br 2003 85 740-747 12892203
16. Huang JI Zuk PA Jones NF Zhu M Lorenz HP Hedrick MH Benhaim P Chondrogenic potential of multipotential cells from human adipose tissue Plast Reconstr Surg 2004 113 585-594 10.1097/01.PRS.0000101063.27008.E1 14758221
17. De Ugarte DA Morizono K Elbarbary A Alfonso Z Zuk PA Zhu M Dragoo JL Ashjian P Thomas B Benhaim P Chen I Fraser J Hedrick MH Comparison of multi-lineage cells from human adipose tissue and bone marrow Cells Tissues Organs 2003 174 101-109 10.1159/000071150 12835573
18. Talmadge JE Reed E Ino K Kessinger A Kuszynski C Heimann D Varney M Jackson J Vose JM Bierman PJ Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow Bone Marrow Transplant 1997 19 161-172 10.1038/ sj.bmt.1700626 9116614
19. Fisher DC Peters WP Advances in the clinical use of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor to intensify cancer chemotherapy Curr Opin Hematol 1994 1 221-227 9371286
20. Allen TD Dexter TM The essential cells of the hemopoietic microenvironment Exp Hematol 1984 12 517-521 6745328
21. Mayani H Guilbert LJ Janowska-Wieczorek A Biology of the hemopoietic microenvironment Eur J Haematol 1992 49 225-233 1473584
22. Yoder MC Williams DA Matrix molecule interactions with hematopoietic stem cells Exp Hematol 1995 23 961-967 7635183
23. O'Shaughnessy JA Tolcher A Riseberg D Venzon D Zujewski J Noone M Gossard M Danforth D Jacobson J Chang V Goldspiel B Keegan P Giusti R Cowan KH Prospective, randomized trial of 5-fluorouracil, leucovorin, doxorubicin, and cyclophosphamide chemotherapy in combination with the interleukin-3/granulocyte-macrophage colony-stimulating factor (GM-CSF) fusion protein (PIXY321) versus GM-CSF in patients with advanced breast cancer Blood 1996 87 2205-2211 8630380
24. Schwartz GN Warren MK Rothwell SW Zujewski J Halverson DC Cowan KH Tolcher A O'Shaughnessy J Gress RE Post-chemotherapy and cytokine pretreated marrow stromal cell layers suppress hematopoiesis from normal donor CD34+ cells Bone Marrow Transplant 1998 22 457-468 10.1038/ sj.bmt.1701364 9733269
25. Edwards RG Stem cells today: B1. Bone marrow stem cells Reprod Biomed Online 2004 9 541-583 15588475
26. Fermand JP Katsahian S Divine M Leblond V Dreyfus F Macro M Arnulf B Royer B Mariette X Pertuiset E Belanger C Janvier M Chevret S Brouet JC Ravaud P High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: Long-term results of a randomized control trial from the Group Myelome-Autogreffe J Clin Oncol 2005 23 9227-9233 10.1200/ JCO.2005.03.0551 16275936
27. Nitz UA Mohrmann S Fischer J Lindemann W Berdel WE Jackisch C Werner C Ziske C Kirchner H Metzner B Souchon R Ruffert U Schutt G Pollmanns A Schmoll HJ Middecke C Baltzer J Schrader I Wiebringhaus H Ko Y Rosel S Schwenzer T Wernet P Hinke A Bender HG Frick M Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: Results of a multicentre phase III trial Lancet 2005 366 1935-1944 10.1016/S0140-6736(05)67784-7 16325695
28. Balduzzi A Valsecchi MG Uderzo C De Lorenzo P Klingebiel T Peters C Stary J Felice MS Magyarosy E Conter V Reiter A Messina C Gadner H Schrappe M Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: Comparison by genetic randomisation in an international prospective study Lancet 2005 366 635-642 10.1016/S0140-6736(05)66998-X 16112299
29. Berthold F Boos J Burdach S Erttmann R Henze G Hermann J Klingebiel T Kremens B Schilling FH Schrappe M Simon T Hero B Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: A randomised controlled trial Lancet Oncol 2005 6 649-658 16129365
30. Dreyling M Lenz G Hoster E Van Hoof A Gisselbrecht C Schmits R Metzner B Truemper L Reiser M Steinhauer H Boiron JM Boogaerts MA Aldaoud A Silingardi V Kluin-Nelemans HC Hasford J Parwaresch R Unterhalt M Hiddemann W Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: Results of a prospective randomized trial of the European MCL Network Blood 2005 105 2677-2684 10.1182/blood-2004-10-3883 15591112
31. Valteau-Couanet D Faucher C Auperin A Michon J Milpied N Boiron JM Bourhis JH Gisselbrecht C Vernant JP Pinna A Bendahmane B Delabarre F Benhamou E Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: Results of a SFGM-TC randomised trial Bone Marrow Transplant 2005 36 547-552 10.1038/ sj.bmt.1705097 16007101
32. Peters WP Rosner GL Vredenburgh JJ Shpall EJ Crump M Richardson PG Schuster MW Marks LB Cirrincione C Norton L Henderson IC Schilsky RL Hurd DD Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: A report of CALGB 9082, SWOG 9114, and NCIC MA-13 J Clin Oncol 2005 23 2191 2200 10.1200/JCO.2005.10.202 15767638
33. Pico JL Rosti G Kramar A Wandt H Koza V Salvioni R Theodore C Lelli G Siegert W Horwich A Marangolo M Linkesch W Pizzocaro G Schmoll HJ Bouzy J Droz JP Biron P A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours Ann Oncol 2005 16 1152 1159 10.1093/ annonc/mdi228 15928070
34. Breems DA Boogaerts MA Dekker AW Van Putten WL Sonneveld P Huijgens PC Van der LJ Vellenga E Gratwohl A Verhoef GE Verdonck LF Lowenberg B Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: A prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial Br J Haematol 2005 128 59-65 10.1111/ j.1365-2141.2004.05282.x 15606550
35. Schmid P Schippinger W Nitsch T Huebner G Heilmann V Schultze W Hausmaninger H Wischnewsky M Possinger K Up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: Results of a randomized trial J Clin Oncol 2005 23 432-440 10.1200/JCO.2005.06.072 15659490
36. Tricot G Jagannath S Vesole D Nelson J Tindle S Miller L Cheson B Crowley J Barlogie B Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients Blood 1995 85 588-596 7529066
37. Boccadoro M Palumbo A Bringhen S Merletti F Ciccone G Richiardi L Rus C Bertola A Giaccone L Omede P Musto P Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma Haematologica 2002 87 846-850 12161361
38. Blair A Baker CL Pamphilon DH Judson PA Ex vivo expansion of megakaryocyte progenitor cells from normal bone marrow and peripheral blood and from patients with haematological malignancies Br J Haematol 2002 116 912-919 10.1046/j.0007-1048.2002.03354.x 11886401
39. McNiece I Jones R Bearman SI Cagnoni P Nieto Y Franklin W Ryder J Steele A Stoltz J Russell P McDermitt J Hogan C Murphy J Shpall EJ Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer Blood 2000 96 3001-3007 11049977
40. Weiss L Or R Slavin S Naparstek E Reich S Abdul-Hai A Immunotherapy of murine leukemia following non-myeloablative conditioning with naive or G-CSF mobilized blood or bone marrow stem cells Cancer Immunol Immunother 2004 53 358-362 10.1007/s00262-003-0440-5 14605765
41. Couban S Simpson DR Barnett MJ Bredeson C Hubesch L Howson-Jan K Shore TB Walker IR Browett P Messner HA Panzarella T Lipton JH A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies Blood 2002 100 1525-1531 10.1182/blood-2002-01-0048 12176866
42. Storek J Dawson MA Storer B Stevens-Ayers T Maloney DG Marr KA Witherspoon RP Bensinger W Flowers ME Martin P Storb R Appelbaum FR Boeckh M Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation Blood 2001 97 3380 3389 10.1182/blood.V97.11.3380 11369627
43. Hernandez MD del Canizo MC Gonzalez M Caballero MD Lopez-Berges MC Vazquez L Orfao A Corral M Nieto MJ San Miguel JF [Immune reconstitution after autologous progenitor hemopoietic cell transplantation. A study comparing autologous bone marrow and autologous peripheral blood transplantation] Med Clin (Barc) 1998 110 768-773 9666417
44. Attal M Harousseau JL Facon T Guilhot F Doyen C Fuzibet JG Monconduit M Hulin C Caillot D Bouabdallah R Voillat L Sotto JJ Grosbois B Bataille R Single versus double autologous stem-cell transplantation for multiple myeloma N Engl J Med 2003 349 2495-2502 10.1056/NEJMoa032290 14695409
45. Szyper-Kravitz M Uziel O Shapiro H Radnay J Katz T Rowe JM Lishner M Lahav M Granulocyte colony-stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapy Br J Haematol 2003 120 329-336 10.1046/j.1365-2141.2003.04043.x 12542495
46. Danova M Porta C Ferrari S Brugnatelli S Comolli G Riccardi A Ascari E Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes and granulocyte colony-stimulating factor in breast cancer patients Oncol Rep 2000 7 585-589 10767372
47. Somlo G Sniecinski I ter Veer A Longmate J Knutson G Vuk-Pavlovic S Bhatia R Chow W Leong L Morgan R Margolin K Raschko J Shibata S Tetef M Yen Y Forman S Jones D Ashby M Fyfe G Hellmann S Doroshow JH Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy Blood 1999 93 2798-2806 10216073
48. Canales MA Arrieta R Hernandez-Garcia C Bustos JG Aguado MJ Hernandez-Navarro F A single apheresis to achieve a high number of peripheral blood CD34+ cells in a lithium-treated patient with acute myeloid leukaemia Bone Marrow Transplant 1999 23 305 10.1038/ sj.bmt.1701566 10084266
49. Prosper F Sola C Hornedo J Arbona C Menendez P Orfao A Lluch A Cortes-Funes H Lopez JJ Garcia-Conde J Mobilization of peripheral blood progenitor cells with a combination of cyclophosphamide, r-metHuSCF and filgrastim in patients with breast cancer previously treated with chemotherapy Leukemia 2003 17 437-441 10.1038/sj.leu.2402750 12592344
50. Hernandez-Boluda JC Carreras E Cervantes F Marin P Arellano-Rodrigo E Rovira M Sole F Lloveras E Espinet B Ocejo A Montserrat E Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon Haematologica 2002 87 17-22 11801461
51. Ross AA Cooper BW Lazarus HM Mackay W Moss TJ Ciobanu N Tallman MS Kennedy MJ Davidson NE Sweet D. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques Blood 1993 82 2605-2610 8219214
52. Dal CL Cottu PH Lotz JP Robert I Extra JM Miclea JM Marty M Marolleau JP Residual tumor cell contamination in peripheral blood stem cells collections of 117 breast cancer patients evaluated by immunocytochemical technique J Hematother Stem Cell Res 2001 10 855-862 10.1089/152581601317210944 11798511
53. Kruger W Togel F Kroger N Rossing S Gieseking F Gutensohn K Lindner C Janicke F Zander AR Tumour cell detection in G-CSF mobilised stem cell harvests of patients with breast cancer Med Oncol 1999 16 17 22 10382938
54. Passos-Coelho JL Ross AA Kahn DJ Moss TJ Davis JM Huelskamp AM Noga SJ Davidson NE Kennedy MJ Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor J Clin Oncol 1996 14 2569 2575 8823337
55. Pedrazzoli P Battaglia M Da Prada GA Lanza A Cuomo A Bertolini F Pavesi L Robustelli della CG Role of tumor cells contaminating the graft in breast cancer recurrence after high-dose chemotherapy Bone Marrow Transplant 1997 20 167-169 10.1038/sj.bmt.1700854 9244422
56. Cooper BW Moss TJ Ross AA Ybanez J Lazarus HM Occult tumor contamination of hematopoietic stem-cell products does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer J Clin Oncol 1998 16 3509-3517 9817268
57. Cagnoni PJ Jones RB Bearman SI Ross M Hami L Franklin WA Capizzi R Schein PS Shpall EJ Use of amifostine in bone marrow purging Semin Oncol 1996 23 44-48 8783666
58. Poloni A Leoni P Curzi L Cantori I Mancini S Montanari M Masia MC Olivieri A Ex vivo pharmacological purging of leukapheresis collections with nitrogen mustard: Amifostine pretreatment improves both early and late peripheral blood progenitor cell recovery Exp Hematol 1999 27 1548-1556 10.1016/S0301-472X(99)00086-7 10517497
59. Altes A Sierra J Esteve J Martin-Henao G Marin P Sureda A Briones J Martino R Villamor N Colomer D Carreras E Garcia J Brunet S Montserrat E CD34+-enriched-CD19+-depleted autologous peripheral blood stem cell transplantation for chronic lymphoproliferative disorders: High purging efficiency but increased risk of severe infections Exp Hematol 2002 30 824-830 10.1016/S0301-472X(02)00828-7 12135682
60. Martin-Rendon E Watt SM Exploitation of stem cell plasticity Transfus Med 2003 13 325-349 10.1111/j.1365-3148.2003.00462.x 14651740
61. Beccheroni A Lucarelli E Donati D Sangiorgi L Capponcelli S Gorini M Zambon BA Giardino R Mercuri M Ferrari S Bacci G Picci P Recovery of stromal stem cells in bone sarcoma patients after chemotherapy: implication for cell-based therapy in bone defect reconstruction Oncol Rep 2003 10 891-896 12792741
62. Jager M Schultheis A Westhoff B Krauspe R Osteogenic progenitor cell potency after high-dose chemotherapy (COSS-96) Anticancer Res 2005 25 947-954 15868932
63. Kang HJ Kim HS Koo BK Kim YJ Lee D Sohn DW Oh BH Park YB Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial Am Heart J 2007 153 237-238 10.1016/ j.ahj.2006.11.004 17239682
64. Klein HM Ghodsizad A Marktanner R Poll L Voelkel T Mohammad Hasani MR Piechaczek C Feifel N Stockschlaeder M Burchardt ER Kar BJ Gregoric I Gams E Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery Heart Surg Forum 2007 10 E66-E69 10.1532/HSF98.20061054 17162408
65. Engelmann MG Theiss HD Hennig-Theiss C Huber A Wintersperger BJ Werle-Ruedinger AE Schoenberg SO Steinbeck G Franz WM Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: Final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial J Am Coll Cardiol 2006 48 1712-1721 10.1016/ j.jacc.2006.07.044 17045910
66. Chawla-Sarkar M Leaman DW Borden EC Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: Correlation with TRAIL/Apo2L induction in melanoma cell lines Clin Cancer Res 2001 7 1821 1831 11410525
67. Lokshin A Mayotte JE Levitt ML Mechanism of interferon beta-induced squamous differentiation and programmed cell death in human non-small-cell lung cancer cell lines J Natl Cancer Inst 1995 87 206-212 10.1093/jnci/87.3.206 7707408
68. Zhang H Koty PP Mayotte J Levitt ML Induction of multiple programmed cell death pathways by IFN-beta in human non-small-cell lung cancer cell lines Exp Cell Res 1999 247 133-141 10.1006/excr.1998.4329 10047455
69. Studeny M Marini FC Dembinski JL Zompetta C Cabreira-Hansen M Bekele BN Champlin RE Andreeff M Mesenchymal stem cells: Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents J Natl Cancer Inst 2004 96 1593-1603 15523088
70. Studeny M Marini FC Champlin RE Zompetta C Fidler IJ Andreeff M Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors Cancer Res 2002 62 3603-3608 12097260
71. Nakamizo A Marini F Amano T Khan A Studeny M Gumin J Chen J Hentschel S Vecil G Dembinski J Andreeff M Lang FF Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas Cancer Res 2005 65 3307-3318 15833864
72. Muller FJ Snyder EY Loring JF Gene therapy: Can neural stem cells deliver? Nat Rev Neurosci 2006 7 75-84 10.1038/nrn1829 16371952
73. Anderson SA Glod J Arbab AS Noel M Ashari P Fine HA Frank JA Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model Blood 2005 105 420-425 10.1182/ blood-2004-06-2222 15331444
74. Hamada H Kobune M Nakamura K Kawano Y Kato K Honmou O Houkin K Matsunaga T Niitsu Y Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy Cancer Sci 2005 96 149-156 10.1111/j.1349-7006.2005.00032.x 15771617
75. Bodnar AG Ouellette M Frolkis M Holt SE Chiu CP Morin GB Harley CB Shay JW Lichtsteiner S Wright WE Extension of life-span by introduction of telomerase into normal human cells Science 1998 279 349-352 10.1126/ science.279.5349.349 9454332
76. Abdallah BM Haack-Sorensen M Burns JS Elsnab B Jakob F Hokland P Kassem M Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation Biochem Biophys Res Commun 2005 326 527-538 10.1016/j.bbrc.2004.11.059 15596132
77. Natesan S Telomerase extends a helping hand to progenitor cells Trends Biotechnol 2005 23 1-3 10.1016/j.tibtech.2004.11.009 15629847
78. Roy NS Nakano T Keyoung HM Windrem M Rashbaum WK Alonso ML Kang J Peng W Carpenter MK Lin J Nedergaard M Goldman SA Telomerase immortalization of neuronally restricted progenitor cells derived from the human fetal spinal cord Nat Biotechnol 2004 22 297-305 10.1038/nbt944 14990951
79. Hung SC Yang DM Chang CF Lin RJ Wang JS Low-Tone HL Yang WK Immortalization without neoplastic transformation of human mesenchymal stem cells by transduction with HPV16 E6/E7 genes Int J Cancer 2004 110 313-319 10.1002/ijc.20126 15095294
80. Finlan LE Hupp TR Epidermal stem cells and cancer stem cells: Insights into cancer and potential therapeutic strategies Eur J Cancer 2006 42 1283-1292 10.1016/j.ejca.2006.01.047 16679013
81. Bixby S Kruger GM Mosher JT Joseph NM Morrison SJ Cell-intrinsic differences between stem cells from different regions of the peripheral nervous system regulate the generation of neural diversity Neuron 2002 35 643-656 10.1016/S0896-6273(02)00825-5 12194865
82. SOUTHAM CM Relationships of immunology to cancer: A review Cancer Res 1960 20 271-291 13833075
83. Hope KJ Jin L Dick JE Human acute myeloid leukemia stem cells Arch Med Res 2003 34 507-514 10.1016/j.arcmed.2003.08.007 14734090
84. Park CH Bergsagel DE McCulloch EA Mouse myeloma tumor stem cells: A primary cell culture assay J Natl Cancer Inst 1971 46 411-422 5115909
85. Bonnet D Dick JE Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat Med 1997 3 730-737 10.1038/nm0797-730 9212098
86. Dick JE Breast cancer stem cells revealed Proc Natl Acad Sci U S A 2003 100 3547-3549 152954 12657737 10.1073/pnas.0830967100
87. Galderisi U Cipollaro M Giordano A Stem cells and brain cancer Cell Death Differ 2006 13 5-11 10.1038/sj.cdd.4401757 16123777
88. Al-Hajj M Wicha MS Ito-Hernandez A Morrison SJ Clarke MF Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci U S A 2003 100 3983-3988 153034 12629218 10.1073/pnas.0530291100
89. Hemmati HD Nakano I Lazareff JA Masterman-Smith M Geschwind DH Bronner-Fraser M Kornblum HI Cancerous stem cells can arise from pediatric brain tumors Proc Natl Acad Sci U S A 2003 100 15178-15183 299944 14645703 10.1073/pnas.2036535100
90. Knudson AG Jr. Strong LC Anderson DE Heredity and cancer in man Prog Med Genet 1973 9:113-58. 113 158
91. Morrison SJ Qian D Jerabek L Thiel BA Park IK Ford PS Kiel MJ Schork NJ Weissman IL Clarke MF A genetic determinant that specifically regulates the frequency of hematopoietic stem cells J Immunol 2002 168-635 642 11777956
92. Al-Hajj M Becker MW Wicha M Weissman I Clarke MF Therapeutic implications of cancer stem cells Curr Opin Genet Dev 2004 14 43-47 10.1016/j.gde.2003.11.007 15108804
93. Sell S Stem cell origin of cancer and differentiation therapy Crit Rev Oncol Hematol 2004 51 1-28 15207251
94. Wang JC Dick JE Cancer stem cells: Lessons from leukemia Trends Cell Biol 2005 15 494-501 10.1016/j.tcb.2005.07.004 16084092
95. Cozzio A Passegue E Ayton PM Karsunky H Cleary ML Weissman IL Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors Genes Dev 2003 17 3029-3035 305255 14701873 10.1101/gad.1143403
96. Jamieson CH Ailles LE Dylla SJ Muijtjens M Jones C Zehnder JL Gotlib J Li K Manz MG Keating A Sawyers CL Weissman IL Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML N Engl J Med 2004 351 657-667 10.1056/NEJMoa040258 15306667
97. Weissman IL Normal and neoplastic stem cells Novartis Found Symp 2005 265:35-50; discussion 50-4, 92-7. 35-50
98. Singh SK Hawkins C Clarke ID Squire JA Bayani J Hide T Henkelman RM Cusimano MD Dirks PB Identification of human brain tumour initiating cells Nature 2004 432 396-401 10.1038/nature03128 15549107
99. Yuan X Curtin J Xiong Y Liu G Waschsmann-Hogiu S Farkas DL Black KL Yu JS Isolation of cancer stem cells from adult glioblastoma multiforme Oncogene 2004 23 9392-9400 10.1038/sj.onc.1208311 15558011
100. Galli R Binda E Orfanelli U Cipelletti B Gritti A De Vitis S Fiocco R Foroni C Dimeco F Vescovi A Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma Cancer Res 2004 64 7011-7021 10.1158/0008-5472.CAN-04-1364 15466194
101. Xin L Lawson DA Witte ON The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis Proc Natl Acad Sci U S A 2005 102 6942-6947 1087514 15860580 10.1073/pnas.0502320102
102. Stockler M Wilcken NR Ghersi D Simes RJ Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer Cancer Treat Rev 2000 26 151-168 10.1053/ctrv.1999.0161 10814559
103. Jordan CT Guzman ML Noble M Cancer stem cells N Engl J Med 2006 355 1253-1261 10.1056/NEJMra061808 16990388
104. Costello RT Mallet F Gaugler B Sainty D Arnoulet C Gastaut JA Olive D Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities Cancer Res 2000 60 4403-4411 10969785
105. Guzman ML Swiderski CF Howard DS Grimes BA Rossi RM Szilvassy SJ Jordan CT Preferential induction of apoptosis for primary human leukemic stem cells Proc Natl Acad Sci U S A 2002 99 16220 16225-138592 12451177 10.1073/pnas.252462599
106. Groszer M Erickson R Scripture-Adams DD Lesche R Trumpp A Zack JA Kornblum HI Liu X Wu H Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo Science 2001 294 2186-2189 10.1126/science.1065518 11691952
107. Park IK Qian D Kiel M Becker MW Pihalja M Weissman IL Morrison SJ Clarke MF Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells Nature 2003 423 302-305 10.1038/nature01587 12714971
108. Blair A Hogge DE Ailles LE Lansdorp PM Sutherland HJ Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo Blood 1997 89 3104-3112 9129012
109. Blair A Sutherland HJ Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117) Exp Hematol 2000 28 660-671 10.1016/ S0301-472X(00)00155-7 10880752
110. Druker BJ Tamura S Buchdunger E Ohno S Segal GM Fanning S Zimmermann J Lydon NB Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells Nat Med 1996 2 561-566 10.1038/ nm0596-561 8616716
111. O'Brien SG Guilhot F Larson RA Gathmann I Baccarani M Cervantes F Cornelissen JJ Fischer T Hochhaus A Hughes T Lechner K Nielsen JL Rousselot P Reiffers J Saglio G Shepherd J Simonsson B Gratwohl A Goldman JM Kantarjian H Taylor K Verhoef G Bolton AE Capdeville R Druker BJ Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia N Engl J Med 2003 348 994-1004 10.1056/NEJMoa022457 12637609
112. Branford S Hughes TP Rudzki Z Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics Br J Haematol 1999 107 587-599 10.1046/ j.1365-2141.1999.01749.x 10583264
113. Berman DM Karhadkar SS Hallahan AR Pritchard JI Eberhart CG Watkins DN Chen JK Cooper MK Taipale J Olson JM Beachy PA Medulloblastoma growth inhibition by hedgehog pathway blockade Science 2002 297 1559-1561 10.1126/science.1073733 12202832
114. Beachy PA Karhadkar SS Berman DM Tissue repair and stem cell renewal in carcinogenesis Nature 2004 432 324-331 10.1038/nature03100 15549094
115. Oehler VG Radich JP Storer B Blume KG Chauncey T Clift R Snyder DS Forman SJ Flowers ME Martin P Guthrie KA Negrin RS Appelbaum FR Bensinger W Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia Biol Blood Marrow Transplant 2005 11 85-92 10.1016/j.bbmt.2004.09.010 15682068
116. Heldal D Brinch L Tjonnfjord G Solheim BG Egeland T Albrechtsen D Aamodt G Evensen SA Fewer relapses and increased chronic GVHD in patients transplanted with blood stem cells: A 5-year follow-up in a single centre study Bone Marrow Transplant 2003 32 257-264 10.1038/ sj.bmt.1704127 12858196
117. Nucci M Andrade F Vigorito A Trabasso P Aranha JF Maiolino A De Souza CA Infectious complications in patients randomized to receive allogeneic bone marrow or peripheral blood transplantation Transpl Infect Dis 2003 5 167-173 10.1111/j.1399-3062.2003.00033.x 14987200
118. Powles R Mehta J Kulkarni S Treleaven J Millar B Marsden J Shepherd V Rowland A Sirohi B Tait D Horton C Long S Singhal S Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: A randomised trial Lancet 2000 355 1231-1237 10.1016/ S0140-6736(00)02090-0 10770306
119. Mahmoud H Fahmy O Kamel A Kamel M El Haddad A El Kadi D Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant 1999 24 355-358 10.1038/ sj.bmt.1701906 10467322
120. Barbui AM Galli M Dotti G Belli N Borleri G Gritti G Bellavita P Viero P Comotti B Barbui T Rambaldi A Negative selection of peripheral blood stem cells to support a tandem autologous transplantation programme in multiple myeloma Br J Haematol 2002 116 202-210 10.1046/ j.0007-1048.2001.03189.x 11841418
121. Stewart AK Vescio R Schiller G Ballester O Noga S Rugo H Freytes C Stadtmauer E Tarantolo S Sahebi F Stiff P Meharchard J Schlossman R Brown R Tully H Benyunes M Jacobs C Berenson R White M DiPersio J Anderson KC Berenson J Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: Results of a multicenter randomized controlled trial J Clin Oncol 2001 19 3771-3779 11533101
122. Vescio R Schiller G Stewart AK Ballester O Noga S Rugo H Freytes C Stadtmauer E Tarantolo S Sahebi F Stiff P Meharchard J Schlossman R Brown R Tully H Benyunes M Jacobs C Berenson R DiPersio J Anderson K Berenson J Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma Blood 1999 93 1858 -868 10068658
123. Shpall EJ Stemmer SM Bearman SI Myers S Purdy M Jones RB New strategies in marrow purging for breast cancer patients receiving high-dose chemotherapy with autologous bone marrow transplantation Breast Cancer Res Treat 1993 26 Suppl S19-S23 10.1007/BF00668356 7691269
124. Huang Y Yang J Wang XB Becker FF Gascoyne PR The removal of human breast cancer cells from hematopoietic CD34+ stem cells by dielectrophoretic field-flow-fractionation J Hematother Stem Cell Res 1999 8 481-490 10.1089/152581699319939 10791899
125. Borbolla-Escoboza JR Leon MI Collados MT Baez E Baltasar S Hernandez R Rojas JC Induction of apoptosis and effect on CD20+ using rituximab on autologous peripheral blood stem cell harvests from patients with B cell lymphomas Stem Cells Dev 2004 13 193-196 10.1089/154732804323046792 15186735
126. Craiu A Saito Y Limon A Eppich HM Olson DP Rodrigues N Adams GB Dombkowski D Richardson P Schlossman R Choi PS Grogins J O'Connor PG Cohen K Attar EC Freshman J Rich R Mangano JA Gribben JG Anderson KC Scadden DT Flowing cells through pulsed electric fields efficiently purges stem cell preparations of contaminating myeloma cells while preserving stem cell function Blood 2005 105 2235-2238 10.1182/ blood-2003-12-4399 15292069
127. Wierenga PK Setroikromo R Kamps G Kampinga HH Vellenga E Differences in heat sensitivity between normal and acute myeloid leukemic stem cells: feasibility of hyperthermic purging of leukemic cells from autologous stem cell grafts Exp Hematol 2003 31 421 427 10.1016/ S0301-472X(03)00049-3 12763141